Results 161 to 170 of about 12,455 (266)

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain [PDF]

open access: gold, 2012
Wu Ou   +9 more
openalex   +1 more source

Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening

open access: bronze, 2004
Jonathan S. Towner   +6 more
openalex   +1 more source

Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein

open access: bronze, 2005
St. Patrick Reid   +2 more
openalex   +1 more source

Ebola [PDF]

open access: yes
Ebola, previously known as Ebola hemorrhagic fever, is a severe, often fatal disease in humans and nonhuman primates (such as monkeys, gorillas, and chimpanzees).Ebola is a rare and deadly disease caused by infection with a virus of the family ...

core  

Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials [PDF]

open access: gold, 2021
Rebecca F. Grais   +10 more
openalex   +1 more source

Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells [PDF]

open access: bronze, 2015
Gordian Schudt   +5 more
openalex   +1 more source

Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin

open access: yesCell Reports, 2023
Rodrigo I Santos   +8 more
semanticscholar   +1 more source

Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection

open access: yesFrontiers in Immunology, 2022
Charles D. Murin   +4 more
doaj   +1 more source

Ebolavirus VP35 Interacts with the Cytoplasmic Dynein Light Chain 8

open access: green, 2009
Toru Kubota   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy